CS McKee’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $975K | Buy |
18,810
+1,860
| +11% | +$96.4K | 0.09% | 85 |
|
|
2019
Q3 | $930K | Hold |
16,950
| – | – | 0.08% | 85 |
|
|
2019
Q2 | $689K | Sell |
16,950
-1,400
| -8% | -$56.9K | 0.06% | 89 |
|
|
2019
Q1 | $555K | Sell |
18,350
-150
| -0.8% | -$4.54K | 0.05% | 97 |
|
|
2018
Q4 | $622K | Hold |
18,500
| – | – | 0.06% | 94 |
|
|
2018
Q3 | $780K | Hold |
18,500
| – | – | 0.06% | 100 |
|
|
2018
Q2 | $592K | Sell |
18,500
-1,000
| -5% | -$32K | 0.05% | 103 |
|
|
2018
Q1 | $970K | Sell |
19,500
-700
| -3% | -$34.8K | 0.08% | 97 |
|
|
2017
Q4 | $1.09M | Buy |
20,200
+100
| +0.5% | +$5.39K | 0.08% | 92 |
|
|
2017
Q3 | $1.17M | Buy |
20,100
+6,000
| +43% | +$348K | 0.09% | 85 |
|
|
2017
Q2 | $696K | Buy |
14,100
+100
| +0.7% | +$4.94K | 0.06% | 97 |
|
|
2017
Q1 | $608K | Sell |
14,000
-100
| -0.7% | -$4.34K | 0.05% | 93 |
|
|
2016
Q4 | $690K | Sell |
14,100
-1,300
| -8% | -$63.6K | 0.05% | 95 |
|
|
2016
Q3 | $737K | Sell |
15,400
-1,850
| -11% | -$88.5K | 0.05% | 94 |
|
|
2016
Q2 | $925K | Sell |
17,250
-20,840
| -55% | -$1.12M | 0.04% | 91 |
|
|
2016
Q1 | $1.7M | Buy |
+38,090
| New | +$1.7M | 0.06% | 88 |
|